Imiquimod and Squamous Cell Cancer

Archives of Dermatology

Volumn 141, Issue 6, 2005, Pages 787-788

  Hengge, Ulrich R ^a   Schaller, Jörg ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE;

BOWEN DISEASE; EPIDERMIS; FOLLOW UP; HISTOLOGY; HUMAN; KERATINOCYTE; NOTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; CASE REPORT; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; PATHOLOGY; PRECANCER; RISK ASSESSMENT; SKIN TUMOR; TREATMENT OUTCOME;

AMINOQUINOLINES; BIOPSY, NEEDLE; BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 21844457402     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.6.787-b     Document Type: Note

References (3)

1. Hengge UR, Schaller J. Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Arch Dermatol. 2004;140:404-406.
2. Prinz BM, Hafner J, Dummer R, Burg G, Bruswanger U, Kempf W. Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation. 2004;77:790-791.
3. Nouri K, O'Connell C, Rivas MP. Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma. J Drugs Dermatol. 2003;2:669-673.